Cell And Gene Therapy Supply Chain/Logistics Market Outlook 2026–2035: Growth Drivers and Industry Forecast
Uncover key drivers, emerging technologies, and competitive movements shaping the cell and gene therapy supply chain/logistics market from 2026–2035 with trusted insights from The Business Research Company
What size range is anticipated for the Cell And Gene Therapy Supply Chain/Logistics Market from 2026 to 2030?
The cell and gene therapy supply chain/logistics market has experienced significant growth recently. This market is projected to expand from $1.58 billion in 2025 to $1.78 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 12.2%. Key contributors to its historical growth include the escalating complexity inherent in cell and gene therapy logistics, the early integration of cryogenic shipping solutions, the development of centralized manufacturing models, a heightened regulatory focus on traceability, and the increased reliance on specialized logistics providers.
The cell and gene therapy supply chain/logistics market is projected for substantial expansion in the upcoming years. By 2030, its valuation is anticipated to reach $2.81 billion, exhibiting a compound annual growth rate (CAGR) of 12.1%. This expansion during the forecast period is primarily driven by factors such as the increasing commercialization of personalized treatments, a heightened need for comprehensive supply chain visibility, the broadening of global therapy distribution channels, the rising uptake of cloud-powered logistics solutions, and increased capital directed towards advanced cold chain infrastructure. Key developments foreseen include the proliferation of integrated cold chain management systems, the increasing implementation of real-time tracking and traceability mechanisms, a greater reliance on cryogenic logistics, the growing incorporation of patient-focused supply chain paradigms, and a stronger emphasis on maintaining chain of custody adherence.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12631&type=smp
What Drivers Are Affecting Demand In The Cell And Gene Therapy Supply Chain/Logistics Market?
The expanding requirement for cell and gene therapies is a primary force driving the cell and gene therapy supply chain or logistics market. These advanced medical treatments modify cells or genes to address diseases, holding considerable promise for conditions that were previously untreatable. Such cell and gene therapies mandate precise temperature and storage conditions, which are effectively managed by supply chain and logistics services that cover everything from sourcing to distribution and storage. For example, in 2023, the American Society of Gene & Cell Therapy, a US-based non-profit medical and scientific organization, reported that the number of gene therapies in Phase III clinical trials increased by 10% in Q3 2023, representing the first quarterly rise since Q3 2022. Therefore, the growing demand for cell and gene therapies continues to propel the cell and gene therapy supply chain or logistics market.
Which Segments Are Gaining Traction In The Cell And Gene Therapy Supply Chain/Logistics Market?
The cell and gene therapy supply chain/logistics market covered in this report is segmented –
1) By Type Of Software Solution: Cell Orchestration Platform, Enterprise Manufacturing System, Inventory Management System, Laboratory Information Management System, Logistics Management System, Patient Management System, Quality Management System, Tracking And Tracing System
2) By Mode Of Deployment: Cloud-Based Solution, On-Premises Solution
3) By Component: Cryogenic Shippers, Cryogenic Storage Freezers, Ultra-Low Freezers, Cold Chain Management Systems, Shipment, Storage Medium, Cryogenic Packout Kits, Other Components
4) By Application Area: Donor Eligibility Assessment, Sample Collection, Manufacturing, Logistics, Patient Verification, Treatment Follow-Up
5) By End User: Biobank, Cell Therapy Lab, Hospital, Research Institute, Commercial Organization
Subsegments:
1) By Cell Orchestration Platform: Workflow Management, Scheduling And Coordination Tools
2) By Enterprise Manufacturing System: Production Planning And Control, Manufacturing Execution Systems (MES)
3) By Inventory Management System: Stock Tracking And Management, Inventory Forecasting And Optimization
4) By Laboratory Information Management System (LIMS): Sample Tracking And Management, Data Management And Reporting
5) By Logistics Management System: Route Optimization And Planning, Transportation Management
6) By Patient Management System: Patient Scheduling And Coordination, Data Management And Tracking Of Patient Outcomes
7) By Quality Management System: Compliance Tracking, Quality Assurance And Control
8) By Tracking And Tracing System: Real-Time Tracking Of Shipments, Chain Of Custody Documentation
What Industry Trends Are Transforming The Cell And Gene Therapy Supply Chain/Logistics Market?
The increasing adoption of modern technology platforms represents a significant trend in the cell and gene therapy supply chain/logistics markets. Key companies operating in this sector are actively developing these advanced platforms for cell and gene therapies to uphold their market position. For example, in April 2023, AmerisourceBergen Corporation, a US-based healthcare company specializing in cell and gene therapy supply chain logistics, unveiled its Cell and Gene Therapy (CGT) Integration Hub. This Cell and Gene Therapy (CGT) Integration Hub is powered by AmerisourceBergen’s innovative customer relationship management (CRM) system and can be integrated into biopharma platforms to enable more effective monitoring of the development and delivery of cell and gene therapies.
Who Are The Top-Performing Companies In The Cell And Gene Therapy Supply Chain/Logistics Market In Recent Years?
Major companies operating in the cell and gene therapy supply chain/logistics market are AmerisourceBergen Corporation, United Parcel Service, Thermo Fisher Scientific Inc., Avantor Sciences, Lonza Group AG, Arvato Group, Catalent Inc., Charles River Laboratories International, Parexel International Corporation, Cytiva, Almac Group, World Courier, Sharp Packaging Services, PCI Pharma Services, Cryoport Inc., Brooks Life Sciences, BioLife Solutions Inc., Biocair Inc., QuickSTAT, Clarkston Consulting Inc., Central Pharma, TrakCel limited, MAK-SYSTEM International Group, Hypertrust Patient Data Care GmbH, Atelerix Ltd., Polar Express Transportation, Be The Match BioTherapies Inc., Yourway Biopharma Services Company, Azenta Life Sciences Inc., Biostor Ltd.
Access The Complete Report For Deeper Market Insights:
Which Region Currently Holds The Largest Share Of The Cell And Gene Therapy Supply Chain/Logistics Market?
North America was the largest region in the cell and gene therapy supply chain/logistics market in 2025. The regions covered in the cell and gene therapy supply chain/logistics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Cell And Gene Therapy Supply Chain/Logistics Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=12631&type=smp
Browse Through More Reports Similar to the Global Cell And Gene Therapy Supply Chain/Logistics Market 2026, By The Business Research Company
Cell And Gene Therapy Clinical Trial Services Market Report 2026
Cell And Gene Therapy Manufacturing Services Market 2026
Cell And Gene Therapy Contract Development And Manufacturing Organization Cdmo Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
